-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Akari Therapeutics Plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2023.
- Akari Therapeutics Plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 23.1M shares, a 14.2% increase year-over-year.
- Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 21.2M shares, a 19.6% increase from 2022.
- Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17.7M shares, a 99.6% decline from 2021.
- Akari Therapeutics Plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 4.29B shares, a 35.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)